Allworth Financial’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Allworth Financial’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-21	Closed	-$233	–	3572
2023 Q2	$233	Hold	21	–	–	﹤0.01%	3070
2023 Q1	$283	Buy	+21	New	+$363	﹤0.01%	2948
2022 Q4	–	Sell	-153	Closed	-$2K	–	3248
2022 Q3	$2K	Buy	+153	New	+$2.46K	﹤0.01%	2269

Other funds holding ICPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Allworth Financial's ICPT Position: Q3 2023 in Review

Allworth Financial sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2023, closing a stake of 21 shares — an estimated $233 sold.

Allworth Financial first reported a position in ICPT in Q3 2022 and held it in 3 quarters. The position peaked at $2K in Q3 2022. 146 funds tracked by Wall St. Rank hold ICPT as of Q3 2023.

Allworth Financial reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Allworth Financial sold 21 Intercept Pharmaceuticals, Inc. shares in Q3 2023, an estimated $233.
Allworth Financial first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2022 and held it in 3 quarters.
Allworth Financial's Intercept Pharmaceuticals, Inc. position peaked at $2K in Q3 2022.
146 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2023.

Based on Allworth Financial's 13F filing for Q3 2023, filed 31 Oct 2023.